ABE	abemaciclib
AIDS	acquired immunodeficiency syndrome
CDK	cyclin-dependent kinase
CDV	cidofovir
CI	combination index
CIwt	weighted combination index
CPE	cytopathic effect
d	day(s)
DAA	direct-acting antiviral(s)
DMEM	Dulbecco’s modified Eagle’s medium
DMSO	dimethyl sulfoxide
DNA	deoxyribonucleic acid
EBV	Epstein-Barr virus
EYFP	enhanced yellow fluorescent protein
FBS	fetal bovine serum
FOS	foscarnet
GCV	ganciclovir
GFP	green fluorescent protein
HCMV	human cytomegalovirus
HDA	host-directed antiviral(s)
HFF	human foreskin fibroblast
HIV	human immunodeficiency virus
LMV	letermovir
MBV	maribavir
MCMV	murine cytomegalovirus
MDV	Marek’s disease virus
MEF	murine embryonic fibroblast
MEM	Eagle’s Minimal Essential medium
MOI	multiplicity of infection
p.i.	post-infection
PBS	phosphate buffered saline
PFU	plaque-forming unit(s)
PKI	pharmaceutical kinase inhibitor
PRA	plaque reduction assay
qPCR	quantitative polymerase chain reaction
rpm	rotations per minute
SD	standard deviation
VGCV	valganciclovir